News
Recursion: Shaking Up The Biopharma Landscape With A Bold, Data-Driven Blueprint Jul. 17, 2023 5:04 PM ET Recursion Pharmaceuticals, Inc. (RXRX) Stock NVDA, RXRX 21 Comments ...
Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.
Recursion Deprioritizes 3 Clinical Programs Following Data-Driven Review, Stock Down May 05, 2025 — 08:46 am EDT Written by RTTNews.com for RTTNews -> ...
Protein Target Data Layer: Mapped 1.4 million active ligands to binding pockets for structure-based drug discovery and target deconvolution.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback